Compare Stocks

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; Pharmaceutics International Inc.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

ClearBridge MLP and Midstream Total Return Fund Inc. is an open ended equity mutual fund of funds launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by ClearBridge Investments, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the energy sector. It primarily invests in equity securities of MLPs, stocks of entities holding primarily general partner or managing member interests in MLPs, and securities that are derivatives of interests in MLPs such as exchange traded funds. ClearBridge MLP and Midstream Total Return Fund Inc. was formed on April 10, 2012 and is domiciled in the United States.

K-Bro Linen Inc., together with its subsidiaries, provides laundry and linen services to healthcare institutions, hotels, and other commercial organizations in Canada and the United Kingdom. Its services include processing, management, and distribution of general and operating room linens, such as sheets, blankets, towels, surgical gowns, tablecloths, and drapes and other linens. The company also offers other services, including bulk dock-to-dock, exchange cart preparation, cart delivery, surgical linen, distribution and control of employee uniforms, personal clothing, customer reporting, customer service visiting, and textile procurement services. In addition, it provides linen rental, workwear hire, and cleanroom garment services. The company was founded in 1954 and is headquartered in Edmonton, Canada.

Metanor Resources Inc. produces and sells gold in Canada. It also explores for and develops mining properties. The company primarily holds interests in the Bachelor mine and the Barry project, as well as approximately 15,000 hectares of exploration properties located in the mining-friendly jurisdiction of Québec. Metanor Resources Inc. was incorporated in 2003 and is headquartered in Val-d'Or, Canada.

The SPDR S&P Dividend ETF seeks to closely match the returns and characteristics of the S&P High Yield Dividend Aristocrats Index (the Index). The Index is designed to measure the performance of the 60 highest dividend yielding S&P Composite 1500 Index constituents that have followed a managed-dividends policy of consistently increasing dividends every year for at least 25 consecutive years. The Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including money market funds advised by the Adviser). SSgA Funds Management, Inc. is the investment adviser to the Fund.